Conversation on 
Twitter :
 |
@FierceBiotech: Alzheimer's drug builds new brain cell connections in rats. Story | Follow @FierceBiotech
@JohnCFierce: New FDA lung cancer OK for Celgene's Abraxane should boost sales. More | Follow @JohnCFierce
@RyanMFierce: Biotech regulars should appreciate this. Actress Jennifer Aniston investing in a Bob Langer company. More | Follow @RyanMFierce
> Large pharma and biotech companies' venture units have stepped up investments in drug developers as some traditional VC groups step back from the risky bets. Nature article
> Lexicon Pharmaceuticals ($LXRX) has launched a Phase III trial for an experimental drug against carcinoid syndrome. Release
> Reuters reports that a different way of analyzing data on Dendreon's ($DNDN) prostate cancer drug Provenge could have boosted the apparent benefits. Article
> Pfizer ($PFE) revealed that ALO-02, an experimental pain drug, appeared as safe as existing formulations in a Phase III study. Item
> Novartis ($NVS) has dropped development of a long-acting antipsychotic drug known as Fanapt from Vanda Pharmaceuticals. Report
Pharma News
@FiercePharma: How is the U.K.'s fund for NICE-nixed cancer drugs faring? Total spent since 10/2010: £180.9M on 18K+ patients. Report | Follow @FiercePharma
> Novartis, Sanofi unveil data backing their rival MS pills. Story
> New FDA lung cancer OK for Celgene's Abraxane should boost sales. Article
> Pfizer aims to keep CEO off the stand in Chantix trial. News
@FierceMedDev: Coming soon: we'll find out if Intuitive Surgical's earnings slowed in Q3 as predicted. Let the speculation begin. More | Follow @FierceMedDev
@MarkHFierce: Medtech industry's efficiency reaches new level, PWC report concludes. Article | Follow @MarkHFierce
@DamianFierce: A federal court has tossed Fresenius' $83M Medicare fraud judgement. More | Follow @DamianFierce
> FDA approves aortic-repair stent grafts. Article
> As it turns to medtech, Sony's credit rating gets lowered. Report
> Observers watch Intuitive Surgical closely for Q3 clues. Story
And Finally… The now notorious New England Compounding, which has been linked with a meningitis scare, faces its first patient lawsuit. Item